VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
osveral
Preclinical
Small molecule
H
Hormozgan University of Medical Sciences
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Transfusional Iron Overload
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Transfusional Iron Overload
Preclinical
Completed
Clinical
Trials by Indication
[1]
Transfusional Iron Overload
1 trial
Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload
Completed
·
H
Hormozgan University of Medical Sciences
·
N/A
·
NCT01369719
·
138 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for osveral. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
osveral compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for osveral. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Hormozgan University of Medical Sciences company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
H
Hormozgan University of Medical Sciences
Related News